Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{$index + 1}}. {{ watchedTerm.term }} ({{watchedTerm.accId}})
{{gene.symbol}}: {{ gene.description }}
Save what matters to you
{{ loginError }}
Sign in with your RGD account
Gene: Hs1bp3 (HCLS1 binding protein 3) Rattus norvegicus
Analyze
Symbol:
Hs1bp3
Name:
HCLS1 binding protein 3
RGD ID:
1311331
Description:
Predicted to have phosphatidylinositol binding activity. Predicted to be involved in regulation of apoptotic process. Predicted to localize to endoplasmic reticulum and mitochondrion. Human ortholog(s) of this gene implicated in essential tremor 2. Orthologous to human HS1BP3 (HCLS1 binding protein 3); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 3-chloropropane-1,2-diol; 6-propyl-2-thiouracil.
Type:
protein-coding
RefSeq Status:
MODEL
Also known as:
HCLS1-binding protein 3; LOC313950; RGD1311331; similar to HS1 binding protein 3
RGD Orthologs
Alliance Genes
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
HS1BP3 (HCLS1 binding protein 3)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoMCL, Panther, Treefam
Mus musculus (house mouse):
Hs1bp3 (HCLS1 binding protein 3)
HGNC
Treefam, EggNOG, OrthoMCL, NCBI, OMA, HomoloGene, Inparanoid, Panther, Ensembl
Chinchilla lanigera (long-tailed chinchilla):
Hs1bp3 (HCLS1 binding protein 3)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
HS1BP3 (HCLS1 binding protein 3)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
HS1BP3 (HCLS1 binding protein 3)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Hs1bp3 (HCLS1 binding protein 3)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
HS1BP3 (HCLS1 binding protein 3)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (African green monkey):
HS1BP3 (HCLS1 binding protein 3)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Hs1bp3 (HCLS1 binding protein 3)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Mus musculus (house mouse):
Hs1bp3 (HCLS1 binding protein 3)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|TreeFam)
Homo sapiens (human):
HS1BP3 (HCLS1 binding protein 3)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|TreeFam)
Danio rerio (zebrafish):
hs1bp3 (HCLS1 binding protein 3)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|TreeFam)
Latest Assembly:
Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Rnor_6.0 6 33,517,711 - 33,548,015 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 6 33,517,769 - 33,548,034 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 6 43,302,675 - 43,333,022 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 6 31,872,303 - 31,902,812 (+) NCBI RGSC3.4 rn4 RGSC3.4 RGSC_v3.1 6 31,872,249 - 31,904,371 (+) NCBI Celera 6 30,642,682 - 30,672,986 (+) NCBI Celera Cytogenetic Map 6 q14 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Imported Disease Annotations - OMIM
(R)-lipoic acid multiple interactions ISO RGD:1553147 6480464 Thioctic Acid inhibits the reaction [Potassium Dichromate results in decreased expression of HS1BP3 mRNA] CTD PMID:23608068 17beta-estradiol decreases expression ISO RGD:1553147 6480464 Estradiol results in decreased expression of HS1BP3 mRNA CTD PMID:14664709 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1602467 6480464 Tetrachlorodibenzodioxin affects the expression of HS1BP3 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1553147 6480464 Tetrachlorodibenzodioxin affects the expression of HS1BP3 mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of HS1BP3 mRNA CTD PMID:22298810 2-methylcholine affects expression ISO RGD:1602467 6480464 beta-methylcholine affects the expression of HS1BP3 mRNA CTD PMID:21179406 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of HS1BP3 mRNA CTD PMID:28522335 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of HS1BP3 mRNA CTD PMID:24780913 aflatoxin B1 increases methylation ISO RGD:1602467 6480464 Aflatoxin B1 results in increased methylation of HS1BP3 intron CTD PMID:30157460 benzo[a]pyrene increases methylation ISO RGD:1602467 6480464 Benzoapyrene results in increased methylation of HS1BP3 promoter CTD PMID:27901495 bisphenol A increases expression ISO RGD:1553147 6480464 bisphenol A results in increased expression of HS1BP3 mRNA CTD PMID:26063408 bisphenol A increases expression ISO RGD:1602467 6480464 bisphenol A results in increased expression of HS1BP3 mRNA CTD PMID:29275510 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of HS1BP3 mRNA CTD PMID:25181051 cisplatin increases expression ISO RGD:1602467 6480464 Cisplatin results in increased expression of HS1BP3 mRNA CTD PMID:27594783 copper(II) sulfate decreases expression ISO RGD:1602467 6480464 Copper Sulfate results in decreased expression of HS1BP3 mRNA CTD PMID:19549813 entinostat increases expression ISO RGD:1602467 6480464 entinostat results in increased expression of HS1BP3 mRNA CTD PMID:27188386 folic acid decreases expression ISO RGD:1553147 6480464 Folic Acid results in decreased expression of HS1BP3 mRNA CTD PMID:25629700 lipoic acid multiple interactions ISO RGD:1553147 6480464 Thioctic Acid inhibits the reaction [Potassium Dichromate results in decreased expression of HS1BP3 mRNA] CTD PMID:23608068 mercury atom decreases expression ISO RGD:1602467 6480464 Mercury results in decreased expression of HS1BP3 mRNA CTD PMID:16823088 mercury(0) decreases expression ISO RGD:1602467 6480464 Mercury results in decreased expression of HS1BP3 mRNA CTD PMID:16823088 methotrexate decreases expression ISO RGD:1602467 6480464 Methotrexate results in decreased expression of HS1BP3 mRNA CTD PMID:24449571 potassium dichromate decreases expression ISO RGD:1553147 6480464 Potassium Dichromate results in decreased expression of HS1BP3 mRNA CTD PMID:23608068 potassium dichromate multiple interactions ISO RGD:1553147 6480464 Thioctic Acid inhibits the reaction [Potassium Dichromate results in decreased expression of HS1BP3 mRNA] CTD PMID:23608068 quercetin increases expression ISO RGD:1602467 6480464 Quercetin results in increased expression of HS1BP3 mRNA CTD PMID:21632981 resveratrol increases expression ISO RGD:1553147 6480464 resveratrol results in increased expression of HS1BP3 protein CTD PMID:25505154 silicon dioxide increases expression ISO RGD:1602467 6480464 Silicon Dioxide analog results in increased expression of HS1BP3 mRNA CTD PMID:25895662 sodium arsenite decreases expression ISO RGD:1602467 6480464 sodium arsenite results in decreased expression of HS1BP3 mRNA CTD PMID:29301061 Soman decreases expression EXP 6480464 Soman results in decreased expression of HS1BP3 mRNA CTD PMID:19281266 sunitinib increases expression ISO RGD:1602467 6480464 Sunitinib results in increased expression of HS1BP3 mRNA CTD PMID:31533062 valproic acid increases expression ISO RGD:1602467 6480464 Valproic Acid results in increased expression of HS1BP3 mRNA CTD PMID:23179753 , PMID:28001369 valproic acid affects expression ISO RGD:1602467 6480464 Valproic Acid affects the expression of HS1BP3 mRNA CTD PMID:25979313
References
Additional References at PubMed
Genomics
QTLs in Region (Rnor_6.0)
738023 Alc17 Alcohol consumption QTL 17 3.1 0.003 consumption behavior trait (VT:0002069) ethanol drink intake rate to body weight ratio (CMO:0001616) 6 1 35623029 Rat 1354616 Despr12 Despair related QTL 12 0.0012 locomotor behavior trait (VT:0001392) amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) 6 1 35623029 Rat 1549905 Stresp10 Stress response QTL 10 6.83 0.0066 stress-related behavior trait (VT:0010451) number of approaches toward negative stimulus before onset of defensive burying response (CMO:0001960) 6 1 35623029 Rat 2300176 Bmd51 Bone mineral density QTL 51 11.7 0.0001 femur mineral mass (VT:0010011) bone mineral density (CMO:0001226) 6 1 35623029 Rat 2300190 Bmd52 Bone mineral density QTL 52 11.2 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 6 1 35623029 Rat 1331743 Uae28 Urinary albumin excretion QTL 28 4.5 urine albumin amount (VT:0002871) urine albumin level (CMO:0000130) 6 1 41917988 Rat 9589048 Scfw3 Subcutaneous fat weight QTL 3 4.57 0.001 subcutaneous adipose mass (VT:1000472) abdominal subcutaneous fat pad weight (CMO:0002069) 6 1 42388212 Rat 9589129 Insul24 Insulin level QTL 24 19.06 0.001 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 6 1 42388212 Rat 7411603 Foco13 Food consumption QTL 13 5.5 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 6 1 42388212 Rat 7411542 Bw127 Body weight QTL 127 5.5 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 6 1 42388212 Rat 8552962 Pigfal16 Plasma insulin-like growth factor 1 level QTL 16 9.4 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 6 1 42388212 Rat 2293709 Bss23 Bone structure and strength QTL 23 5.18 0.0001 femur morphology trait (VT:0000559) femur cross-sectional area (CMO:0001661) 6 1 43665660 Rat 2293650 Bss31 Bone structure and strength QTL 31 5.05 0.0001 femur strength trait (VT:0010010) femur midshaft polar moment of inertia (CMO:0001669) 6 1 43665660 Rat 2293656 Bss28 Bone structure and strength QTL 28 6.79 0.0001 femur morphology trait (VT:0000559) femur midshaft cortical cross-sectional area (CMO:0001663) 6 1 43665660 Rat 7411584 Foco4 Food consumption QTL 4 4.3 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 6 1 44015370 Rat 738024 Sach5 Saccharine consumption QTL 5 3.9 0.00039 consumption behavior trait (VT:0002069) saccharin intake volume to total fluid intake volume ratio (CMO:0001601) 6 1 44570292 Rat 2301972 Bp325 Blood pressure QTL 325 4.8 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 6 1 75623393 Rat 2292589 Emca10 Estrogen-induced mammary cancer QTL 10 0.048 mammary gland integrity trait (VT:0010552) post-insult time to mammary tumor formation (CMO:0000345) 6 1120393 46120393 Rat 1354664 Slep2 Serum leptin concentration QTL 2 4.49 blood leptin amount (VT:0005667) serum leptin level (CMO:0000780) 6 1120393 75023446 Rat 1576309 Emca7 Estrogen-induced mammary cancer QTL 7 4 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 6 2537030 111715717 Rat 1578665 Bss16 Bone structure and strength QTL 16 4.4 femur morphology trait (VT:0000559) bone trabecular cross-sectional area (CMO:0002311) 6 6161722 76002731 Rat 1578668 Bmd14 Bone mineral density QTL 14 3.8 femur mineral mass (VT:0010011) total volumetric bone mineral density (CMO:0001728) 6 6161722 76002731 Rat 4145119 Mcs25 Mammary carcinoma susceptibility QTL 25 0.0001 mammary gland integrity trait (VT:0010552) ratio of deaths to total study population during a period of time (CMO:0001023) 6 7009971 115379601 Rat 634322 Bw12 Body weight QTL 12 0 body mass (VT:0001259) body weight (CMO:0000012) 7 10173862 55173862 Rat 1300128 Rf16 Renal function QTL 16 3.89 renal blood flow trait (VT:2000006) absolute change in renal blood flow rate (CMO:0001168) 6 13122958 34367603 Rat 1300164 Rf15 Renal function QTL 15 3.12 renal blood flow trait (VT:2000006) absolute change in renal blood flow rate (CMO:0001168) 6 13122958 57516539 Rat 10401812 Kidm54 Kidney mass QTL 54 kidney mass (VT:0002707) both kidneys wet weight (CMO:0000085) 6 16810107 61810107 Rat 10401800 Kidm49 Kidney mass QTL 49 kidney mass (VT:0002707) both kidneys wet weight (CMO:0000085) 6 16810107 61810107 Rat 8552910 Pigfal5 Plasma insulin-like growth factor 1 level QTL 5 4.3 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 6 19417887 64417887 Rat 1641898 Colcr4 Colorectal carcinoma resistance QTL4 3.71 0.0007 intestine integrity trait (VT:0010554) well differentiated malignant colorectal tumor surface area measurement (CMO:0002077) 6 21515302 65784818 Rat 2293839 Kiddil2 Kidney dilation QTL 2 4.8 kidney pelvis morphology trait (VT:0004194) hydronephrosis severity score (CMO:0001208) 6 22042854 84763421 Rat 2293841 Kiddil4 Kidney dilation QTL 4 4.4 kidney pelvis morphology trait (VT:0004194) hydronephrosis severity score (CMO:0001208) 6 22042854 84763421 Rat